Nyrada (ASX:NYR) Total Receivables: A$3.24 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:NYR Nyrada Inc ASX:NYR
35 GF Score
Price A$0.41
! 1 Warning Sign
View Full Analysis

What is Nyrada Total Receivables?

Nyrada ASX:NYR -4.65% 35 Total Receivables is A$3.24 Mil as of Dec. 2025. GuruFocus rates ASX:NYR with a GF Score™ of 35/100. The stock has 1 warning sign investors should review.

Nyrada's Total Receivables for the quarter that ended in Dec. 2025 was A$3.24 Mil.

Nyrada Total Receivables Historical Data

* Premium members only.

The historical data trend for Nyrada's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nyrada Total Receivables Chart

Nyrada Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Receivables
Get a 7-Day Free Trial 1.36 1.07 1.34 1.02 2.29

Nyrada Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 1.02 0.79 2.29 3.24
ASX:NYR
35GF Score
Nyrada Inc ASX:NYR
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nyrada Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of A$3.24 Mil mean?
Nyrada (ASX:NYR) has a Total Receivables of A$3.24 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Nyrada and its competitors.
Is Nyrada's Total Receivables too high?
Nyrada's current Total Receivables is A$3.24 Mil. Overall, Nyrada has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Nyrada's Total Receivables compare to VRTX and REGN?
Nyrada's Total Receivables of A$3.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Nyrada and its competitors. Nyrada's current Total Receivables is A$3.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nyrada stock overvalued right now?
Nyrada (ASX:NYR) has a current Total Receivables of A$3.24 Mil. The current Total Receivables is A$3.24 Mil. Nyrada's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Nyrada (ASX:NYR), the current Total Receivables is A$3.24 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nyrada Business Description

Address 180 George Street, Sydney Place, Level 22/23, Salesforce Tower, Sydney, NSW, AUS, 2000
Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. It operates in one segment: research and development of drugs focusing on small molecules with potential therapeutic benefit in areas of medical needs. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.
35GF Score

Get the complete analysis for ASX:NYR

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.41
Price